Cargando…
HIV vaccine trial safety and retention among 18-20 year olds in the HVTN 503/Phambili study support the inclusion of adolescents in future trials
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441785/ http://dx.doi.org/10.1186/1742-4690-9-S2-P131 |
| _version_ | 1782243375393538048 |
|---|---|
| author | Volk, JE Hessol, NA Gray, GE Kublin, JG Churchyard, G Mlisana, K Nchabeleng, M Buchbinder, SP Bekker, L |
| author_facet | Volk, JE Hessol, NA Gray, GE Kublin, JG Churchyard, G Mlisana, K Nchabeleng, M Buchbinder, SP Bekker, L |
| author_sort | Volk, JE |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3441785 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-34417852012-09-18 HIV vaccine trial safety and retention among 18-20 year olds in the HVTN 503/Phambili study support the inclusion of adolescents in future trials Volk, JE Hessol, NA Gray, GE Kublin, JG Churchyard, G Mlisana, K Nchabeleng, M Buchbinder, SP Bekker, L Retrovirology Poster Presentation BioMed Central 2012-09-13 /pmc/articles/PMC3441785/ http://dx.doi.org/10.1186/1742-4690-9-S2-P131 Text en Copyright ©2012 Volk et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Volk, JE Hessol, NA Gray, GE Kublin, JG Churchyard, G Mlisana, K Nchabeleng, M Buchbinder, SP Bekker, L HIV vaccine trial safety and retention among 18-20 year olds in the HVTN 503/Phambili study support the inclusion of adolescents in future trials |
| title | HIV vaccine trial safety and retention among 18-20 year olds in the HVTN 503/Phambili study support the inclusion of adolescents in future trials |
| title_full | HIV vaccine trial safety and retention among 18-20 year olds in the HVTN 503/Phambili study support the inclusion of adolescents in future trials |
| title_fullStr | HIV vaccine trial safety and retention among 18-20 year olds in the HVTN 503/Phambili study support the inclusion of adolescents in future trials |
| title_full_unstemmed | HIV vaccine trial safety and retention among 18-20 year olds in the HVTN 503/Phambili study support the inclusion of adolescents in future trials |
| title_short | HIV vaccine trial safety and retention among 18-20 year olds in the HVTN 503/Phambili study support the inclusion of adolescents in future trials |
| title_sort | hiv vaccine trial safety and retention among 18-20 year olds in the hvtn 503/phambili study support the inclusion of adolescents in future trials |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441785/ http://dx.doi.org/10.1186/1742-4690-9-S2-P131 |
| work_keys_str_mv | AT volkje hivvaccinetrialsafetyandretentionamong1820yearoldsinthehvtn503phambilistudysupporttheinclusionofadolescentsinfuturetrials AT hessolna hivvaccinetrialsafetyandretentionamong1820yearoldsinthehvtn503phambilistudysupporttheinclusionofadolescentsinfuturetrials AT grayge hivvaccinetrialsafetyandretentionamong1820yearoldsinthehvtn503phambilistudysupporttheinclusionofadolescentsinfuturetrials AT kublinjg hivvaccinetrialsafetyandretentionamong1820yearoldsinthehvtn503phambilistudysupporttheinclusionofadolescentsinfuturetrials AT churchyardg hivvaccinetrialsafetyandretentionamong1820yearoldsinthehvtn503phambilistudysupporttheinclusionofadolescentsinfuturetrials AT mlisanak hivvaccinetrialsafetyandretentionamong1820yearoldsinthehvtn503phambilistudysupporttheinclusionofadolescentsinfuturetrials AT nchabelengm hivvaccinetrialsafetyandretentionamong1820yearoldsinthehvtn503phambilistudysupporttheinclusionofadolescentsinfuturetrials AT buchbindersp hivvaccinetrialsafetyandretentionamong1820yearoldsinthehvtn503phambilistudysupporttheinclusionofadolescentsinfuturetrials AT bekkerl hivvaccinetrialsafetyandretentionamong1820yearoldsinthehvtn503phambilistudysupporttheinclusionofadolescentsinfuturetrials |